Subscribe to RSS
Download PDF
DOI: 10.1055/s-0042-1759768
Analysis of Traditional Chinese Medicine Syndromes and Treatment Laws of Diabetic Kidney Disease and the Action Mechanism of High-Frequency Chinese Herbs in the Treatment of Diabetic Kidney Disease Based on Real-World Study
Funding This work was supported by the National Key Research Project (2020YFE0201800), Henan Province Science and Technology Program for Tackling Key Problems (21210230347), and 2021 Postgraduate Scientific Research Innovation Program of Henan University of Chinese Medicine (2021KYCX008).
- Abstract
- Introduction
- Retrospective Study on Traditional Chinese Medicine Syndromes and Treatment Laws of Diabetic Kidney Disease Based on Real-World Study
- Research on the Action Mechanism Based on Network Pharmacology
- Discussion
- Conclusion
- References
Abstract
Objective Our objective was to analyze the traditional Chinese medicine (TCM) syndrome and treatment laws of diabetic kidney disease (DKD) and the action mechanism of high-frequency Chinese herbs in the treatment of DKD based on real-world study.
Methods The data of patients with DKD who had been treated in the First Hospital Affiliated to Henan University of Chinese Medicine from January 1, 2014 to December 31, 2021 were retrospectively analyzed through the hospital information management system. The contents of the cases were statistically analyzed using IBM SPSS Statistics 25 software, and the laws of DKD treatment were summarized. Network pharmacology and molecular docking were used to analyze the action mechanism of high-frequency Chinese herbs in the treatment of DKD.
Results The data of a total of 1,201 patients with DKD were included, involving 72 kinds of TCM syndromes. Nine disease nature elements and six disease location elements were extracted, involving 405 Chinese herbs. The top five high-frequency Chinese herbs were Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), and Danshen (Salviae Miltiorrhizae Radix et Rhizoma). Thirty kinds of Chinese herbs with the frequency of ≥100 were mainly deficiency-tonifying herbs and blood-activating and stasis-eliminating herbs. The medicinal properties were mainly warm and mild, and the medicinal flavors were sweet and bitter mostly. For the meridian tropism, the main meridian tropism of these herbs is spleen meridian and lung meridian. The clustering method aggregated the 30 commonly used Chinese herbs into six categories. A total of 58 effective active ingredients of high-frequency Chinese herbs and 164 related targets were screened based on the traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP); 1,434 targets of DKD and 90 potential targets of high-frequency Chinese herbs for DKD were obtained. “Active ingredient-potential target” network topology analysis indicated that quercetin, luteolin, 7-O-methylisoxitol, hederagenin, and 4-methylene miltirone were the five core chemical components of high-frequency Chinese herbs in the treatment of DKD. Protein–protein interaction network topology analysis indicated that protein kinase B1, interleukin-6, tumor necrosis factor, vascular endothelial growth factor A, tumor protein P53 were the core protein targets. Twenty signaling pathways were obtained by Kyoto Encyclopedia of Genes and Genomes enrichment analysis. Molecular docking showed that luteolin, 4-methylene miltirone, and osthole had strong binding to AKT1.
Conclusion The differentiation and treatment of DKD with TCM follows the principles of “taking kidney as the root, considering both the liver and spleen, tonifying qi and nourishing yin, promoting blood circulation and resolving blood stasis.” High-frequency Chinese herbs for the treatment of DKD have multicomponent, multitarget, and multipath characteristics.
Keywords
diabetic kidney disease - laws of syndromes and treatment - high-frequency Chinese Herbs - real-world study - TCM - network pharmacology - molecular docking - diabetes mellitus - action mechanismIntroduction
Diabetic kidney disease (DKD) is a chronic kidney disease caused by diabetes mellitus (DM). The clinical characteristics of DKD are that the estimated glomerular filtration rate (eGFR) is less than 60 ml min−1 ·1.73m2)−1 or persistent albuminuria.[1] The incidence of DKD in diabetic patients worldwide is as high as 40%, which significantly increases the mortality of diabetic patients.[2] As far as the clinical status is concerned, Western medicine treatment of DKD cannot prevent the development process of the disease.[3] In recent years, it has been found that traditional Chinese medicine (TCM) plays an increasingly obvious role in alleviating symptoms such as fatigue, edema, lumbar soreness, reducing urinary protein content, protecting kidney function, and improving prognosis in DKD patients and is gradually recognized and valued.[4] At present, it lacks high-level evidence-based medical research on the efficacy of DKD, and its mechanism needs to be further clarified.
Randomized controlled trials, clinical observation analysis, and cohort study analysis are the main methods of TCM clinical trials based on the current medical model, and TCM clinical trials have their own relative perfect theoretical systems from ancient times to the present. Therefore, the direct application of modern medical clinical research methods in TCM clinical trials will inevitably lead to some problems. Real-world study (RWS) is the process of collecting relevant information about patients in the actual medical environment and analyzing the benefits and risks of herbs. The adaptability of the two has changed to some extent. RWS evaluates the effects of herbs on large numbers of users in a real medical environment. This study aims to combine real clinical data with bio-information technology, study evidence and treatment strategies, analyze the characteristics of Chinese medicine in treating DKD, clarify the action mechanism of high-frequency Chinese herbs, and provide standard treatment guidelines for DKD.
Retrospective Study on Traditional Chinese Medicine Syndromes and Treatment Laws of Diabetic Kidney Disease Based on Real-World Study
Materials and Methods
Sources of Materials
The First Hospital Affiliated to the Henan University of Chinese Medicine provided experimental data for this study. The electronic medical records of DKD patients who had received treatment in the department of endocrinology from January 1, 2014 to December 31, 2021 were read through the hospital information management system to obtain the case data of patients with the first visit. The ethics committee of the First Hospital Affiliated to Henan University of Chinese Medicine approved this experimental study (ethical batch No: 022HL-080-01).
Diagnostic Criteria
Western medicine diagnostic criteria: cases with a history of DM were searched according to the Chinese Guidelines for the Clinical Diagnosis and Treatment of Diabetic Nephropathy [5] and the Chinese Guidelines for the Prevention and Treatment of Diabetic Nephropathy,[6] and DKD could be diagnosed if one of the following conditions was met: (1) The urinary albumin creatine rate (UACR) or urinary albumin excretion rate (UAER) was detected three times within 3 to 6 months, and UACR ≥ 30 mg/g or UAER ≥ 30 mg/24 h occurred at least twice. (2) The kidney biopsy was consistent with the pathological changes of DKD, such as nodular glomerulosclerosis and diffuse glomerulosclerosis. (3) eGFR < 60 ml min−1 ·1.73m2)−1 for more than 3 months. It can be considered as DKD with liver and kidney yin deficiency and blood stasis syndrome if three of the following five items, together with item 6 from TCM diagnostic criteria are met: according to liver and kidney yin deficiency and blood stasis syndrome in the Internal Medicine of Chinese Medicine (Zhong Yi Nei Ke Xue),[7] the Development and Application of TCM Syndrome Differentiation Guidelines for Diabetic Nephropathy,[8] and the 2011 Edition of TCM Prevention and Treatment Guidelines for Diabetic Nephropathy: (1) turbid urine and frequent and profuse urination; (2) fatigue, shortness of breath, and laziness to speak; (3) dry throat and mouth, feverish palms, and soles; (4) insomnia and dreaminess; (5) palpitation and restlessness; (6) dark or red thin tongue, or tortuous sublingual veins, petechia and ecchymosis, and deep pulse.
Inclusion Criteria
Inclusion criteria were (1) cases conforming the above diagnostic criteria; (2) relatively complete cases in the system data (such as definite and confirmed diseases); (3)mainly Chinese medicine compounds and certain Western medicine prescriptions used; and (4) the treatment outcome (such as recovery or death) clearly reflected in the case information.
Exclusion Criteria
Exclusion criteria were (1) pregnant, lactating, and menstruating women; (2) concomitant with other serious organic diseases (such as cancer); (3) concomitant with other primary or secondary renal disease and systemic disease; (4) various recent emergencies and infections occurred during data acquisition; and (5) patients with mental disorders and allergies.
Data Standardization and Database Establishment
The syndrome patterns of DKD are standardized by referring to the Guidelines for Combination of Diabetes and Nephropathy,[9] such as classifying the “Qi Yin Kui Xu Zheng (qi and yin deficiency syndrome)” as the “Qi Yin Liang Xu Zheng (deficiency syndrome of both qi and yin).” According to the syndrome patterns of DKD included in the clinical data in Science of Syndrome Elements Syndrome Differentiation (Zheng Su Bian Zheng Xue),[10] the involved syndrome patterns are structurally divided according to “syndrome pattern = disease location element + disease nature elements.” The names, efficacies, flavors, and meridian tropism of Chinese herbs involved in the administration of herbs by patients were standardized through the 2020 edition of the Pharmacopoeia of the People's Republic of China.[11] For example, the specifications of “Xueshen” and “Honggen” were “Danshen (Salviae Miltiorrhizae Radix et Rhizoma)”, “Huaishan” was “Shanyao (Dioscoreae Rhizoma)”, “Erhua” and “Shuanghua” were “Jinyinhua (Lonicerae Japonicae Flos)”, and “Jinbuchang” was “Sanqi (Notoginseng Radix et Rhizoma)”. In the Excel 2016 software database, components were input by individual independent retrieval and checked by two people and double computers. The data processing software IBM SPSS Statistics 25 was used to perform statistical analysis of the case contents and draw corresponding charts as required.[12]
Results
Distribution Analysis of Syndrome Patterns
According to the screening and processing of previous case data, a total of 1,201 patients with DKD were obtained, including 72 TCM syndrome patterns, with a total frequency of 1,749 times. DKD includes deficiency syndrome and excess syndrome. Spleen and kidney deficiency syndrome is the most common,[13] complicated with the most frequent phlegm-dampness, blood stasis, and turbid toxin, see [Table 1].
Abbreviations: DKD, diabetic kidney disease; TCM, traditional Chinese medicine.
Analysis of Disease Nature Element and Disease Location Element
According to the analysis, nine disease nature elements were extracted, including two deficiency syndrome elements (qi deficiency and yin deficiency) and seven excess syndrome elements (blood stasis, dampness accumulation, turbid toxin, phlegm and blood stasis, heat toxin, dampness turbidity, and qi stagnation), with a total frequency of 1,643 times. The proportion of qi deficiency and yin deficiency in the deficiency syndrome elements was relatively high; blood stasis was the most frequent evidence of excess syndrome element, followed by dampness accumulation and turbid toxicity, see [Table 2]. Six disease location elements were extracted, with a total frequency of 916 times. The disease location element with the highest frequency was the kidney, followed by the spleen, liver and lung, see [Table 3].
Abbreviation: DKD, diabetic kidney disease.
|
Disease location element |
Frequency/times |
Frequency/% |
|---|---|---|
|
Kidney |
435 |
47.48 |
|
Spleen |
420 |
45.85 |
|
Liver |
25 |
2.72 |
|
Lung |
15 |
1.63 |
|
Stomach |
12 |
1.31 |
|
Heart |
9 |
0.98 |
Abbreviation: DKD, diabetic kidney disease.
Frequency Analysis of Herbs
Through the extraction and correction of experimental data, a total of 1,201 prescriptions were included, involving 405 Chinese herbs. The cumulative frequency of the use of Chinese herbs was 11,366 times. The top five high-frequency Chinese herbs were Baizhu (Atractylodis Macrocephalae Rhizoma; 435 times), Fuling (Poria; 415 times), Huangqi (Astragali Radix; 403 times), Chuanxiong (Chuanxiong Rhizoma; 278 times), and Danshen (Salviae Miltiorrhizae Radix et Rhizoma; 265 times), see [Table 4].
Abbreviation: DKD, diabetic kidney disease.
Analysis of Efficacy Categories and Meridian Tropism of the Properties and Flavors of the Commonly Used Chinese Herbs
Through screening and analysis of the 30 commonly used Chinese herbs with a frequency of ≥100 times, the cumulative frequency of use was 5,585 times. The efficacy categories of Chinese herbs were mainly deficiency tonifying herbs (2,083 times, 40.44%), blood-activating, and stasis-dispelling herbs (899 times, 17.45%); the herb properties were mainly warm (9 times, 29.03%) and mild (7 times, 22.58%); the herbs of sweetness (16 times, 34.78%) and bitterness (13 times, 28.26%) were the most common. As to meridian tropism, the main meridian tropism was the spleen meridian (19 times, 19.00%) and lung meridian (14 times, 14.00%), see [Figure 1].
Clustering of Commonly Used Chinese Herbs
Combined with the characteristics of the syndromes of DKD and clinical practice, the top 30 high-frequency Chinese herbs include Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), Gancao (Glycyrrhizae Radix et Rhizoma), Chenpi (Citri Reticulatae Pericarpium), Danggui (Angelicae Sinensis Radix), Guizhi (Cinnamomi Ramulus), Baishao (Paeoniae Alba Radix), Yiyiren (Coicis Semen), Chishao (Paeoniae Rubra Radix) Qingbanxia (Pinelliae Rhizoma Praeparatum cum Alumine), Shanyao (Dioscoreae Rhizoma), Chuanniuxi (Cyathulae Radix), Dilong (Pheretima), Huanglian (Coptidis Rhizoma), Sharen (Amomi Fructus), Dahuang (Rhei Radix et Rhizoma), Jixuecao (Centellae Herba), Zhishi (Aurantii Fructus Immaturus), Maidong (Ophiopogonis Radix), Houpo (Magnoliae Officinalis Cortex), Taizishen (Pseudostellariae Radix), Shuizhi (Hirudo), Honghua (Carthami Flos), Dangshen (Codonopsis Radix), Zexie (Alismatis Rhizoma), Gegen (Puerariae Lobatae Radix), Shudihuang (Rehmanniae Radix Praeparata). According to the average intergroup connection, the 30 commonly used Chinese herbs were reasonably clustered into six categories, see [Figure 2] and [Table 5].
Research on the Action Mechanism Based on Network Pharmacology
Materials and Methods
Screening of Active Ingredients of High-Frequency Herbs and the Related Targets
The chemical composition of herbs (high-frequency herbs) with a frequency of ≥100 times was retrieved by using the TCM systems pharmacology database and analysis platform, TCMSP (TCMSP, http://tcmspw.com/tcmsp.php), and the effective components and the action targets of Chinese herbs were screened under the conditions of oral bioavailability ≥30% and herblikeness (DL) ≥ 0.18. The target gene names were standardized through the UniProt (https://sparql.uniprot.org) online platform.
Target Screening of Diabetic Kidney Disease
The GeneGards database (http://www.genecards.org), DisGeNET database (https://www.disgenet.org/), and online mendelian inheritance in man (OMIM, https://www.omim.org/) were searched with the keyword “diabetic kidney disease” to obtain the disease target and finally get the collection of disease targets.
"Active Ingredients–Potential Targets" Network and Protein–Protein Interaction Network Construction
The intersections of the targets of high-frequency Chinese herbs and the disease targets of DKD were achieved by using the Venn online network platform (http://bioinfogp.cnb.csic.es/tools/venny/), and the intersection targets were the potential targets of high-frequency Chinese herbs for the treatment of DKD. The potential targets and their corresponding active ingredients were input into Cytoscape 3.7.2 software to construct the “active ingredient-potential target” network graph, and the core chemical composition was screened by topological analysis. The potential targets were imported into STRING database (http://cn.string-db.org), protein–protein interaction (PPI) network was constructed, and key targets were screened by topological analysis.
Analysis of Signal Pathway Enrichment in Kyoto Encyclopedia of Genes and Genomes
The intersection targets were input into the Metascape database (https://metascape.org) for Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway enrichment analysis.
Validation of Docking Between Key Active Ingredients and Key Target Protein Molecules
The key proteins in the top three of the number of nodes in the PPI network were molecularly interfaced with the core components in the top five of the network degree of the “active ingredient-potential target” by using AutoDock software.
Results
Prediction Results of the Active Ingredients and Action Targets of the High-Frequency Herbs
Based on the screening of TCMSP, 58 active ingredients, including Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), and Danshen (Salviae Miltiorrhizae Radix et Rhizoma) and 164 herb action targets were obtained.
Target Screening of Diabetic Kidney Disease
According to the databases of GeneGards, OMIM, and DisGeNET, etc., 2,253 DKD targets were obtained, and a total of 1,434 targets were obtained after integration and deduplication.
“Active Ingredients—Potential Target” Network and Protein–Protein Interaction Network Construction
Using the Venn online network platform, the intersections of high-frequency Chinese medicine targets and DKD targets were selected, and 90 intersection targets were screened out, which were potential targets of high-frequency Chinese herbs for the treatment of DKD. The “active ingredient-potential target” network graph includes 222 nodes (58 active ingredients and 164 target genes). Topological analysis indicated that quercetin, luteolin, 7-O-methylisoxitol, hederagenin, and 4-methylene miltirone were the five core chemical components of high-frequency Chinese herbs for the treatment of DKD, as shown in [Fig. 3]. Ninety potential targets were input into the STRING database and the PPI network was plotted, as shown in [Fig. 4]. The network topology analysis suggested that the top five target proteins were protein kinase B1 (AKT1), interleukin-6 (IL-6), tumor necrosis factor (TNF), vascular endothelial growth factor A (VEGFA), and tumor protein P53 (TP53).
Analysis of Kyoto Encyclopedia of Genes and Genomes Pathway Enrichment
The enrichment analysis of KEGG showed that the key targets were mainly enriched in 20 signaling pathways including tumor-associated pathways (pathways in cancer, proteoglycans in cancer, and transcriptional misregulation in cancer), viral infection-associated pathways (human cytomegalovirus infection, malaria, and epithelial cell signaling in helicobacter pylori infection) and glucose metabolism-associated signaling pathways (AGE-RAGE signaling pathway in diabetic complications, NK-kappa B signaling pathway, diabetic cardiomyopathy, and viral myocarditis), as shown in [Fig. 5].
Verification of Docking Between the Key Active Ingredients of High-Frequency Herbs and Core Protein Molecules
It was found that luteolin, 4-methylene neoketone, and hederagenin had strong binding to AKT1 with binding energies of −6.72 kJ/mol−1, −7.2 kJ/mol−1, and −8.13 kJ/mol−1, respectively. The potential binding sites were mainly the amino acid residues of TRP-99, LYS-39, GLU-40, GLU-91, LYS-8, TRP-11, GLU-95, HIS-13, as shown in [Fig. 6]. Through analysis, it was discovered that luteolin, 4-methylene neoketone, and hederagenin all had multiple active groups, and their chemical structures were highly similar, forming hydrogen bonds with amino acids with an average of 2.45, suggesting that the hydrogen bond distance was short, and it also reflected that the three chemical components could well match the active pocket of AKT1 core protein, see [Fig. 7].
Discussion
There is no clear record of the name of DKD in TCM classics and the literature. Through clinical symptom analysis, DKD can be classified into the categories of “Xiao Ke or Xiao Dan” (consumptive thirst), “edema”, “kidney consumption”, and “urine turbidity”.[14] It is recorded in Formulas from Benevolent Sages Compiled during the Taiping Era (Tai Ping Sheng Hui Fang) that “Three Xiaos (consumptions) are originated from kidney deficiency”. The kidney stores essence and is the innate foundation of human beings. In ancient times, it is generally believed that consumptive thirst is related to kidney deficiency and blood stasis in collaterals.[15] The liver governs the free flow of qi. As early as given in Ling Shu:Wubian ( Spiritual Pivot:Five Changes), it has the description of consumptive thirst caused by emotional disturbance, and this is an early record of “consumption caused by emotions”. In the Treatise on the Three Consumption (San Xiao Lun), it believes that the disease is caused by excessive five emotions and led by excessive anger which will lead to endogenous internal fire and results in consumptive thirst.[16] As the saying goes in Jingui Zhenyan Lun(Discussion on the Important Ideas in the Golden Chamber of Huangdi's Cannon of Internal Medicine), the abdomen belongs to yin, and the yin within yin is kidney; the abdomen belongs to yin, and the yang within yin is the liver. Both the liver and kidney are situated in the lower Jiao, with one pertaining to yang and the other yin. The kidney governs storage and the liver governs the free flow of qi. They work together to dominate the generation of essence and blood so as to nourish the meridians of the whole body. The spleen is the root of the acquired constitution among the five internal organs, which governs qi and blood production and dominates transportation and transformation.[17] According to the characteristics of different stages of DKD, the great TCM master Boshou Xue emphasized the importance of spleen-strengthening, kidney-nourishing, dampness-dissolving, and turbidity-purging in the treatment of DKD.[18] Through real-world data analysis, it discovered that in DKD, spleen and kidney deficiency syndrome, high-frequency syndrome patterns of syndrome of blood stasis obstructing the collaterals, and the disease location elements mainly include the kidney, liver, spleen, etc., while the commonly used herbs mainly pertain to the kidney meridian, liver meridian, and spleen meridian. It can be seen that in the clinical syndrome differentiation and treatment of DKD, the kidney should be taken as the root, liver and spleen should be regulated, the kidney should be nourished and the liver should be softened, so as to achieve kidney–spleen harmony and liver–kidney cotreatment.
Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), and Danshen (Salviae Miltiorrhizae Radix et Rhizoma) are the top five high-frequency Chinese herbs in clinical application. Huangqi Powder can slow down the development of DKD by inhibiting the signaling pathways of phosphatidylinositol 3-kinase/protein kinase B (AKT)/mammalian target of rapamycin (mTOR).[19] Huangqi (Astragali Radix), Baizhu (Atractylodis Macrocephalae Rhizoma), and Fuling (Poria) in the Supplemented Qiwei Baizhu Powder have the effects of supplementing qi and nourishing yin and have good curative effects on the clinical treatment of DKD.[20] It also shows that although there are many causes of DKD, they are generally summarized as the imbalance between yin and yang, disorder of qi and blood, deficiency, and excess. Huangqi (Astragali Radix), Fuling (Poria) plus Danshen (Salviae Miltiorrhizae Radix et Rhizoma), and Chuanxiong (Chuanxiong Rhizoma) have the effects of removing dampness and relieving swelling, and simultaneously promoting blood circulation and resolving blood stasis, promoting qi circulation and relieving pain.[21] Qiqi Dihuang Pill was found to have a significant protective effect on DKD, which may be related to the reduction of inflammatory response and oxidative stress damage in the body.[22] To sum up, in the treatment of DKD, the Chinese herbs with the effects of supplementing qi and nourishing yin, promoting blood circulation, and resolving blood stasis should be well and skilfully used so that the herbs can directly reach the disease sites to exert their curative effects.
The data analysis showed that DKD is mainly treated with warm and sweet herbs. The most widely used herbs are deficiency-invigorating herbs, diuresis-promoting and dampness-diffusing herbs, blood-activating and stasis-dispelling herbs, etc., which correspond to the blood stasis, dampness accumulation, qi deficiency, etc., in the disease nature elements. Through literature study combined with the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 edition), the Chinese Clinical Guidelines for the Prevention and Control of Type 2 Diabetes in the Elderly (2022 edition) and cluster analysis results,[23] [24] [25] it was indicated that “promoting blood circulation and resolving blood stasis” and “reducing mass and dredging the collaterals” were the therapeutic principles of DKD. Through clinical studies, Dan Tang found that Chinese herbs with functions of promoting blood circulation and resolving blood stasis, reducing mass, and dredging the collaterals have remarkable effects on DKD.[26] To sum up, in the clinical treatment of DKD, we should pay attention to the overall “harmony” in the compatibility of the herbs in the prescription.
The high-frequency Chinese herbs found in this study are Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), etc., which have a high coincidence with the Chinese medicine composition of Zhenhua Li's Yishen Tongluo Prescription. Both of them reflect the principle of tonifying the kidney and dredging the collaterals. Through clustering and implicit structure analysis, it showed that the Chinese herbs with effects of tonifying the kidney and dredging the collaterals have good clinical effects on DKD. Quercetin, luteolin, 7-O-methylisoxitol, hederagenin, and 4-methylene neoketone were the key active ingredients of the above-mentioned herbs. Quercetin is a flavanol compound widely existing in the plant world. It can promote the release of inflammatory factors of IL-1, IL-8, etc., by regulating the renal NF-κB signaling pathway and reduce inflammation and ease the development process of DKD; it can also protect the damage caused by DKD by intervening TGF-β1 and Smad7 pathways by alleviating oxidative stress response in the body[27] [28]; Huangqi Guizhi Wuwu Decoction can reduce the complications of DKD.[29] Luteolin is a flavonoid in Danshen (Salviae Miltiorrhizae Radix et Rhizoma), which can delay the development of DKD.[30] Yao et al found that the glomerular basement membrane hyperplasia and fat inflammation of diabetic mice were well relieved after the use of hederagenin through three omics studies.[31] AKT1, IL-6, TNF, VEGFA, and TP53 are important potential action targets of high-frequency Chinese herbs of Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Huangqi (Astragali Radix), Chuanxiong (Chuanxiong Rhizoma), and Danshen (Salviae Miltiorrhizae Radix et Rhizoma) in the treatment of DKD. It was found that Huangqi (Astragali Radix) (quercetin and hederagenin) can regulate autophagy through negative regulation of AKT1/mTOR signaling pathway in the development of DKD.[32] Bupi Yishen Huoxue Decoction can delay the development of DKD by reducing the levels of IL-6 and TNF-α.[33]
Conclusion
Based on the real-world data, this paper makes a preliminary study on the syndrome laws of DKD and the action mechanism of high-frequency Chinese herbs through retrospective analysis, network pharmacology, molecular docking, etc. It has found that the differentiation and treatment of DKD with TCM follows the principles of “taking kidney as the root, considering both the liver and spleen, tonifying qi and nourishing yin, promoting blood circulation and resolving blood stasis.” High-frequency Chinese herbs for the treatment of DKD have multicomponent, multitarget, and multipath characteristics. This can provide a basis for the clinical treatment of DKD. However, the proper integrative treatment by Chinese medicine and Western medicine needs to be effectively discussed in combination with the actual clinical situation.
Conflict of Interest
The authors declare no conflict of interest.
CRediT Authorship Contribution Statement
Keyi Ji: Writing -original draft, methodology, validation. Genlin Li: Methodology, project administration. Suhui Wu: Resources, supervision. Jiayao Yuan: Formal analysis, supervision. Zheng Du: Data curation, investigation. Hanbing Li: Conceptualization, supervision. Jiangyan Xu: Funding acquisition resources, writing-review & editing.
-
References
- 1 Tuttle KR, Bakris GL, Bilous RW. et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 2014; 64 (04) 510-533
- 2 Zhou XF, Zhou WE, Liu WJ. et al. A network pharmacology approach to explore the mechanism of Huangzhi Yishen capsule for treatment of diabetic kidney disease. J Transl Int Med 2021; 9 (02) 98-113
- 3 Zhou SZ, Zhang YM, He ZR. et al. Risk prediction model constructing and verification of diabetic kidney disease based on the treatment with Chinese medicine. Lishizhen Med Mater Med Res 2021; 32 (06) 1505-1509
- 4 Wang Y, Zhou JW, Wang Z. et al. Recent advances in Chinese and western medicine treatments for diabetic kidney disease. Chin Gen Pract 2022; 25 (12) 1411-1417
- 5 Expert Group of Chinese Society of Nephrology. The Chinese Guidelines for the Clinical Diagnosis and Treatment of Diabetic Nephropathy. Chin J Nephrol 2021; 37 (03) 255-304
- 6 The Microvascular Complications Group of Chinese Diabetes Association. The Chinese Guidelines for the Prevention and Treatment of Diabetic Nephropathy. Chin J Diabetes Mellit 2019; 11 (01) 15-28
- 7 Zhang GY, Sun FX, Xu FQ. Chinese Internal Medicine (Zhong Yi Nei Ke Xue). Jinan: Shandong Science and Technology Press Co., Ltd.; 2020: 181
- 8 Liu Q, Yin ZW, Duan SW. et al. Development and application of TCM syndrome differentiation guidelines for diabetic nephropathy. Chin J Kidney Dis Investig 2018; 7 (02) 91-93 (Electron Ed)
- 9 Xu JY, Jiang H. Research progress of traditional Chinese medicine in treating diabetic nephropathy. J Pract Tradit Chin Intern Med 2022; 36 (06) 33-36
- 10 Zhu WF. Science of Syndrome Elements and Syndrome differentiation. Beijing: People's Medical Publishing House Co., LTD.; 2008: 319
- 11 National Pharmacopoeia Committee. 2020 edition of the Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science Press,; 2020
- 12 Jin G, Feng ZH, Zhao YB. et al. Retrospective real world study on the laws of traditional Chinese medicine syndrome treatment and the mechanism of high-frequency herbs in primary insomnia. Zhongguo Yiyuan Yaoxue Zazhi 2022; 42 (05) 549-554
- 13 Yu JY, Ni Q, Liu S. Diagnosis and treatment guidelines of diabetic kidney disease based on the combination of disease and syndromes. J Tradit Chin Med 2022; 63 (02) 190-197
- 14 Li YN, Gu F, Yang YF. et al. Study on etiology, pathogenesis and treatment of diabetes based on theory of Huangdi Neijing . J Pract Tradit Chin Intern Med 2022; 36 (02) 32-34
- 15 Zhang QX. Basic Theory of Chinese Medicine. Jinan: Shandong Science and Technology Press Co., Ltd.; 2020: 163
- 16 Huang JH, Deng XM, Chen C. et al. Discussion on the mechanism of treating type 2 diabetes mellitus with Wuwei Quenching Prescription based on San Xiao Theory . Clin J Tradit Chin Med 2019; 31 (06) 1017-1019
- 17 Chen ZY, Chen QM, Chen C. Treating diabetes according to “Yin-fire theory”. Acta Chin Med Pharmacol 2022; 50 (05) 13-15
- 18 Zhang J, Wang YQ, Wang YG, Professor XUE. Boshou's experience guides the treatment of diabetic nephropathy with the method of Sanjiao syndrome differentiation. Tianjin J Tradit Chin Med 2020; 37 (04) 398-401
- 19 Lie BF, Cheng F, Duan TT. et al. Effect of Huangqisan pellets on PI3K/Akt/mTOR signaling pathway and autophagy in kidney of diabetic nephropathy rats. Zhongguo Shiyan Fangjixue Zazhi 2022; 28 (07) 11-17
- 20 Zeng GZ. Observation of the efficacy of supplemented Qiwei Baizhu Powder on type-2 diabetic kidney disease in the early stage. Diabetes New World 2018; 21 (06) 165-166 , 171
- 21 Ning XF, Chen Q. Analysis of ZHANG Zhong-jing's treatment on xiaoke disease. Inn Mong J Tradit Chin Med 2021; 40 (06) 138-139
- 22 Li XS, Fang MR, Jiang WJ. et al. Protective effect and mechanism of Qiqi Dihuang Pill on diabetic nephropathy rats. Pharmacol Clin Chin Mater Med 2019; 35 (03) 127-133
- 23 Jiang XF, Zheng QC, Huang CH. et al. Research overview of the TCM etiology and pathogenesis of diabetic nephropathy. Henan Tradit Chin Med 2016; 36 (05) 924-926
- 24 Wang FJ, Wang WQ. Explanations of the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 edition). J Hebei Med Univ 2021; 42 (12) 1365-1371
- 25 Editing group of the Chinese Clinical Guidelines for the Prevention and Control of Diabetes in the Elderly. Chinese Clinical Guidelines for the Prevention and Control of Type 2 Diabetes in the Elderly (2022 edition). Chin J Diabetes 2022; 30 (01) 2-51
- 26 Tang D. The clinical effects of Chinese herbs with functions of activating blood circulation, resolving blood stasis, reducing mass and dredging collaterals on diabetic kidney disease patients and their kidney function. Chronic Pathematology J 2021; 22 (05) 747-748 , 751
- 27 Wang XH, Zheng YP, Sun ML. et al. Experimental study on influence of quercetin on kidney p38MAPK/NF-κB signaling pathway in diabetic rats. Pharmacol Clin Chin Mater Med 2016; 32 (01) 79-82
- 28 Zhu KM, Tang LX, Zhao WP. et al. Effects of quercetin liposomes on oxidative stress and TGF-β1/Smad7 pathway in kidney of diabetic rats. Acta Univ Med Anhui 2017; 52 (03) 319-323
- 29 Fang Y, Wang YD, Zhou W. et al. Effect of Huangqi Guizhi Wuwu Decoction on AGEs/RAGE/NF-κB signaling pathways in diabetic peripheral neuropathy rats. Zhongguo Shiyan Fangjixue Zazhi 2020; 26 (13) 52-58
- 30 Wang L, Yu SJ. Influence of Yishen Huoxue Prescription on the expression of NF-κB in rats with diabetic kidney disease. Pharmacol Clin Chin Mater Med 2015; 31 (02) 158-159
- 31 Yao Y, Zhao X, Xin J, Wu Y, Li H. Coumarins improved type 2 diabetes induced by high-fat diet and streptozotocin in mice via antioxidation. Can J Physiol Pharmacol 2018; 96 (08) 765-771
- 32 Yao Q, Ye TS, Zhang YW. et al. Discussion on the mechanism of Radix astragali seu hedysari in reducing proteinuria in diabetic nephropathy based on network pharmacology and Akt1/mTOR autophagy pathway. Mod Tradit Chin Med Mater Med World Sci Technol 2021; 23 (08) 2699-2710
- 33 Zhao YQ, Chen XD. Effect analysis of Bipi Yishen Decoction in the treatment of diabetic kidney disease. Shenzhen J Integr Tradit Chin West Med 2020; 30 (05) 13-15
Address for correspondence
Publication History
Received: 14 June 2022
Accepted: 27 August 2022
Article published online:
30 December 2022
© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Tuttle KR, Bakris GL, Bilous RW. et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 2014; 64 (04) 510-533
- 2 Zhou XF, Zhou WE, Liu WJ. et al. A network pharmacology approach to explore the mechanism of Huangzhi Yishen capsule for treatment of diabetic kidney disease. J Transl Int Med 2021; 9 (02) 98-113
- 3 Zhou SZ, Zhang YM, He ZR. et al. Risk prediction model constructing and verification of diabetic kidney disease based on the treatment with Chinese medicine. Lishizhen Med Mater Med Res 2021; 32 (06) 1505-1509
- 4 Wang Y, Zhou JW, Wang Z. et al. Recent advances in Chinese and western medicine treatments for diabetic kidney disease. Chin Gen Pract 2022; 25 (12) 1411-1417
- 5 Expert Group of Chinese Society of Nephrology. The Chinese Guidelines for the Clinical Diagnosis and Treatment of Diabetic Nephropathy. Chin J Nephrol 2021; 37 (03) 255-304
- 6 The Microvascular Complications Group of Chinese Diabetes Association. The Chinese Guidelines for the Prevention and Treatment of Diabetic Nephropathy. Chin J Diabetes Mellit 2019; 11 (01) 15-28
- 7 Zhang GY, Sun FX, Xu FQ. Chinese Internal Medicine (Zhong Yi Nei Ke Xue). Jinan: Shandong Science and Technology Press Co., Ltd.; 2020: 181
- 8 Liu Q, Yin ZW, Duan SW. et al. Development and application of TCM syndrome differentiation guidelines for diabetic nephropathy. Chin J Kidney Dis Investig 2018; 7 (02) 91-93 (Electron Ed)
- 9 Xu JY, Jiang H. Research progress of traditional Chinese medicine in treating diabetic nephropathy. J Pract Tradit Chin Intern Med 2022; 36 (06) 33-36
- 10 Zhu WF. Science of Syndrome Elements and Syndrome differentiation. Beijing: People's Medical Publishing House Co., LTD.; 2008: 319
- 11 National Pharmacopoeia Committee. 2020 edition of the Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science Press,; 2020
- 12 Jin G, Feng ZH, Zhao YB. et al. Retrospective real world study on the laws of traditional Chinese medicine syndrome treatment and the mechanism of high-frequency herbs in primary insomnia. Zhongguo Yiyuan Yaoxue Zazhi 2022; 42 (05) 549-554
- 13 Yu JY, Ni Q, Liu S. Diagnosis and treatment guidelines of diabetic kidney disease based on the combination of disease and syndromes. J Tradit Chin Med 2022; 63 (02) 190-197
- 14 Li YN, Gu F, Yang YF. et al. Study on etiology, pathogenesis and treatment of diabetes based on theory of Huangdi Neijing . J Pract Tradit Chin Intern Med 2022; 36 (02) 32-34
- 15 Zhang QX. Basic Theory of Chinese Medicine. Jinan: Shandong Science and Technology Press Co., Ltd.; 2020: 163
- 16 Huang JH, Deng XM, Chen C. et al. Discussion on the mechanism of treating type 2 diabetes mellitus with Wuwei Quenching Prescription based on San Xiao Theory . Clin J Tradit Chin Med 2019; 31 (06) 1017-1019
- 17 Chen ZY, Chen QM, Chen C. Treating diabetes according to “Yin-fire theory”. Acta Chin Med Pharmacol 2022; 50 (05) 13-15
- 18 Zhang J, Wang YQ, Wang YG, Professor XUE. Boshou's experience guides the treatment of diabetic nephropathy with the method of Sanjiao syndrome differentiation. Tianjin J Tradit Chin Med 2020; 37 (04) 398-401
- 19 Lie BF, Cheng F, Duan TT. et al. Effect of Huangqisan pellets on PI3K/Akt/mTOR signaling pathway and autophagy in kidney of diabetic nephropathy rats. Zhongguo Shiyan Fangjixue Zazhi 2022; 28 (07) 11-17
- 20 Zeng GZ. Observation of the efficacy of supplemented Qiwei Baizhu Powder on type-2 diabetic kidney disease in the early stage. Diabetes New World 2018; 21 (06) 165-166 , 171
- 21 Ning XF, Chen Q. Analysis of ZHANG Zhong-jing's treatment on xiaoke disease. Inn Mong J Tradit Chin Med 2021; 40 (06) 138-139
- 22 Li XS, Fang MR, Jiang WJ. et al. Protective effect and mechanism of Qiqi Dihuang Pill on diabetic nephropathy rats. Pharmacol Clin Chin Mater Med 2019; 35 (03) 127-133
- 23 Jiang XF, Zheng QC, Huang CH. et al. Research overview of the TCM etiology and pathogenesis of diabetic nephropathy. Henan Tradit Chin Med 2016; 36 (05) 924-926
- 24 Wang FJ, Wang WQ. Explanations of the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 edition). J Hebei Med Univ 2021; 42 (12) 1365-1371
- 25 Editing group of the Chinese Clinical Guidelines for the Prevention and Control of Diabetes in the Elderly. Chinese Clinical Guidelines for the Prevention and Control of Type 2 Diabetes in the Elderly (2022 edition). Chin J Diabetes 2022; 30 (01) 2-51
- 26 Tang D. The clinical effects of Chinese herbs with functions of activating blood circulation, resolving blood stasis, reducing mass and dredging collaterals on diabetic kidney disease patients and their kidney function. Chronic Pathematology J 2021; 22 (05) 747-748 , 751
- 27 Wang XH, Zheng YP, Sun ML. et al. Experimental study on influence of quercetin on kidney p38MAPK/NF-κB signaling pathway in diabetic rats. Pharmacol Clin Chin Mater Med 2016; 32 (01) 79-82
- 28 Zhu KM, Tang LX, Zhao WP. et al. Effects of quercetin liposomes on oxidative stress and TGF-β1/Smad7 pathway in kidney of diabetic rats. Acta Univ Med Anhui 2017; 52 (03) 319-323
- 29 Fang Y, Wang YD, Zhou W. et al. Effect of Huangqi Guizhi Wuwu Decoction on AGEs/RAGE/NF-κB signaling pathways in diabetic peripheral neuropathy rats. Zhongguo Shiyan Fangjixue Zazhi 2020; 26 (13) 52-58
- 30 Wang L, Yu SJ. Influence of Yishen Huoxue Prescription on the expression of NF-κB in rats with diabetic kidney disease. Pharmacol Clin Chin Mater Med 2015; 31 (02) 158-159
- 31 Yao Y, Zhao X, Xin J, Wu Y, Li H. Coumarins improved type 2 diabetes induced by high-fat diet and streptozotocin in mice via antioxidation. Can J Physiol Pharmacol 2018; 96 (08) 765-771
- 32 Yao Q, Ye TS, Zhang YW. et al. Discussion on the mechanism of Radix astragali seu hedysari in reducing proteinuria in diabetic nephropathy based on network pharmacology and Akt1/mTOR autophagy pathway. Mod Tradit Chin Med Mater Med World Sci Technol 2021; 23 (08) 2699-2710
- 33 Zhao YQ, Chen XD. Effect analysis of Bipi Yishen Decoction in the treatment of diabetic kidney disease. Shenzhen J Integr Tradit Chin West Med 2020; 30 (05) 13-15